Fred B. Craves - Jun 25, 2024 Form 4 Insider Report for MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Role: Director
Signature: /s/ Mardi Dier, as Attorney-in-Fact
Stock symbol: MDGL
Transactions as of: Jun 25, 2024
Transactions value $: $0
Form type: 4
Date filed: 6/27/2024, 09:46 PM
Previous filing: Jun 13, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MDGL	Common Stock	Award	$0	+714	+0.19%	$0.00	375K	Jun 25, 2024	Direct	F1
holding	MDGL	Common Stock						11.2K	Jun 25, 2024	See Footnote	F2
holding	MDGL	Common Stock						1.26K	Jun 25, 2024	See Footnote	F3
holding	MDGL	Common Stock						18K	Jun 25, 2024	See Footnote	F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MDGL	Stock Option (Right to Buy)	Award	$0	+1.11K		$0.00	1.11K	Jun 25, 2024	Common Stock	1.11K	$280.04	Direct	F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a grant of restricted stock units, which vest on June 25, 2025, provided the Reporting Person continues in service with the Issuer on such date.
F2	Represents shares held indirectly by Dr. Craves through a grantor retained annuity trust.
F3	These securities are held by Bay City Capital LLC ("BCC"). Dr. Craves disclaims beneficial ownership of these securities held by BCC, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such shares, except to the extent of his pecuniary interest, if any, in the securities by virtue of the limited liability company interests he owns in BCC.
F4	Represents shares held indirectly by Dr. Craves through the Craves Family Foundation.
F5	The option vests as to 100% of underlying shares on the first anniversary of the grant date, provided that the Reporting Person continues to serve as a director of the Issuer until such anniversary date.